DOWNLOAD CATALOGUE

Our Company
- Our Corporate Structure
Our Science
- Innovative Generics (Gx+)
  - Our Innovation Strategy
  - Our Innovative Projects
- Pharma Manufacturing & QC
Our Products & Services
- Our Products in Greece

Your Career
Ελληνικά

0

$0.00

✕

MARKET AVAILABILITY

DPP‑4 inhibitor

Home
Προϊόν PHARMACOLOGICAL CLASS
DPP‑4 inhibitor

Dipeptidyl peptidase-4 inhibitors or gliptins

THERAPEUTIC AREA -

Allergy
Anesthesiology
Cardio-Renal-Metabolic (CRM)
Cardiology / Diagnostic imaging
Cardiovascular
Cardiovascular / Antithrombotic therapy
Cardiovascular / Cardiology
Cardiovascular / Dyslipidemia
Cardiovascular / Hypertension
Chronic Kidney Disease
Endocrinology
Endocrinology / Bone metabolism
Endocrinology / Diabetes
Gastroenterology
Hepatology / MASH
Immunology
Infectious diseases
Iron deficiency
Menopause
Musculoskeletal disorders
Nephrology
Neurology
Neurology / Alzheimer's disease
Neurology / Epilepsy
Neurology / Parkinson's disease
Neurology / Peripheral neuropathy
Obstetrics
Oncology
Oncology / Endocrinology
Oncology / Hematology
Oncology / Urology
Psychiatry
Psychiatry / Neurology
Radiology / Diagnostic imaging
Radiology / MRI contrast enhancement

PHARMACOLOGICAL CLASS +

Acetylcholinesterase inhibitor
Aldosterone Receptor Antagonist
Alzheimer’s disease
Anticoagulant
Antidepressant
Antidote / Biochemical modulator
Antiepileptic
Antihyperlipidemic
Antihypertensive
Antimigraine
Antineoplastic
Antiplatelet
Antipsychotic
ARNI + SGLT2 Inhibitor Combination Therapy
Aromatase inhibitor
Biological lubricant
Bisphosphonate
Calcimimetic
Cardiac Myosin Inhibitor
Cholinesterase inhibitor
Coronary vasodilator
Diagnostic
DPP‑4 inhibitor
Echinocandin antifungal
Folate analogue
GnRH agonist
Hypnotic
Immunotherapy
Iron supplement
Leukotriene receptor antagonist
Molecular Imaging
Monoamine oxidase type B (MAO‑B) inhibitor
NK-3 Receptor Antagonist
Oral hypoglycemic
Pyrimidine synthesis inhibitor
Selective relaxant binding agent (SRBA)
SGLT-2 Inhibitor
Skeletal muscle relaxant
Thyroid Hormone Receptor-beta (THR-β) Agonist
Vitamin B complex
Vitamin D

BUSINESS UNIT +

CNS
Contrast Media Agents
Oncology
Primary Care
Radiopharmaceutical

ACTIVE SUBSTANCE +

Abiraterone
Agomelatine
Aledronate
Amlodipine/Valsartan
Apixaban
Aripiprazole
Atorvastatin
Bacillus Calmette-Guerin
Baclofen
Bempedoic acid
Bempedoic acid / Ezetimibe
Brexpiprazole
Brivaracetam
Calcium Folinate
Capecitabine
Cholecalciferol
Cinacalcet
Clopidogrel
Dapagliflozin
Dapagliflozin/Metformin
Daridorexant
Donepezil
Duloxetine
Edoxaban
Everolimus
Exametazime
Exemestane
Ezetimibe/Atorvastatin
Ezetimibe/Simvastatin
Ferric carboxymaltose
Ferrous Gluconate
Fezolinetant
Finerenone
Fluciclovine (18F)
Fludeoxyglucose (18F)
Flutemetamol (18F)
Folinic Acid
Gadobutrol
Gadoteric Acid
Hyaluronate Sodium
Iobenguane (123I)
Iodine 123 - Ioflupane
Iodixanol
Iohexol
Iron sucrose
Letrozole
Leuprorelin
Levetiracetam
Linagliptin
Linagliptin/Metformin
Losartan/Hydrochlorothiazide
Lurasidone
Mavacamten
Memantine
Micafungin
Montelukast
Nebivolol
Olanzapine
Paliperidone
Perflutren
Pitavastatin
Pravastatin/Fenofibrate
Quetiapine
Rasagiline
Regadenoson
Resmetirom
Rivaroxaban
Rivastigmine
Rosa canina
Rosuvastatin
Rosuvastatin/Ezetimibe
Sacubitril
Safinamide mesylate
Selenium (75Se) Tauroselcholic Acid
Sitagliptin
Sitagliptin/Metformin
Sodium Iodide (123I)
Sugammadex
Sumatriptan
Technetium (99mTc) Nanocolloid
Teriflunomide
Tetrofosmin
Thiamine/Pyridoxine/Cyanocobalamin
Ticagrelor
Topiramate
Valsartan
Valsartan/Hydrochlorothiazide
Venlafaxine
Vinorelbine
Vortioxetine

PRESCRIPTION REQUIREMENT +

OTC (over-the-counter)
Rx (prescription required)

MARKETING AUTHORISATION HOLDER +

Blue Earth Diagnostics
GE Healthcare A.S.
Krka d.d.
Laboratoires Servier Industrie
Laboratoires SMB S.A.
Medi-Radiopharma (MRP)
Pharmazac S.A.
Provident Pharmaceuticals Ltd
Radiopharmacy Laboratorium KFT., Hungary
Synthaverse S.A.
TAD Pharma GmbH

Linagliptin
Meliglix®

PHARMAZAC

THERAPEUTIC AREA -

Allergy
Anesthesiology
Cardio-Renal-Metabolic (CRM)
Cardiology / Diagnostic imaging
Cardiovascular
Cardiovascular / Antithrombotic therapy
Cardiovascular / Cardiology
Cardiovascular / Dyslipidemia
Cardiovascular / Hypertension
Chronic Kidney Disease
Endocrinology
Endocrinology / Bone metabolism
Endocrinology / Diabetes
Gastroenterology
Hepatology / MASH
Immunology
Infectious diseases
Iron deficiency
Menopause
Musculoskeletal disorders
Nephrology
Neurology
Neurology / Alzheimer's disease
Neurology / Epilepsy
Neurology / Parkinson's disease
Neurology / Peripheral neuropathy
Obstetrics
Oncology
Oncology / Endocrinology
Oncology / Hematology
Oncology / Urology
Psychiatry
Psychiatry / Neurology
Radiology / Diagnostic imaging
Radiology / MRI contrast enhancement

PHARMACOLOGICAL CLASS +

Acetylcholinesterase inhibitor
Aldosterone Receptor Antagonist
Alzheimer’s disease
Anticoagulant
Antidepressant
Antidote / Biochemical modulator
Antiepileptic
Antihyperlipidemic
Antihypertensive
Antimigraine
Antineoplastic
Antiplatelet
Antipsychotic
ARNI + SGLT2 Inhibitor Combination Therapy
Aromatase inhibitor
Biological lubricant
Bisphosphonate
Calcimimetic
Cardiac Myosin Inhibitor
Cholinesterase inhibitor
Coronary vasodilator
Diagnostic
DPP‑4 inhibitor
Echinocandin antifungal
Folate analogue
GnRH agonist
Hypnotic
Immunotherapy
Iron supplement
Leukotriene receptor antagonist
Molecular Imaging
Monoamine oxidase type B (MAO‑B) inhibitor
NK-3 Receptor Antagonist
Oral hypoglycemic
Pyrimidine synthesis inhibitor
Selective relaxant binding agent (SRBA)
SGLT-2 Inhibitor
Skeletal muscle relaxant
Thyroid Hormone Receptor-beta (THR-β) Agonist
Vitamin B complex
Vitamin D

BUSINESS UNIT +

CNS
Contrast Media Agents
Oncology
Primary Care
Radiopharmaceutical

ACTIVE SUBSTANCE +

Abiraterone
Agomelatine
Aledronate
Amlodipine/Valsartan
Apixaban
Aripiprazole
Atorvastatin
Bacillus Calmette-Guerin
Baclofen
Bempedoic acid
Bempedoic acid / Ezetimibe
Brexpiprazole
Brivaracetam
Calcium Folinate
Capecitabine
Cholecalciferol
Cinacalcet
Clopidogrel
Dapagliflozin
Dapagliflozin/Metformin
Daridorexant
Donepezil
Duloxetine
Edoxaban
Everolimus
Exametazime
Exemestane
Ezetimibe/Atorvastatin
Ezetimibe/Simvastatin
Ferric carboxymaltose
Ferrous Gluconate
Fezolinetant
Finerenone
Fluciclovine (18F)
Fludeoxyglucose (18F)
Flutemetamol (18F)
Folinic Acid
Gadobutrol
Gadoteric Acid
Hyaluronate Sodium
Iobenguane (123I)
Iodine 123 - Ioflupane
Iodixanol
Iohexol
Iron sucrose
Letrozole
Leuprorelin
Levetiracetam
Linagliptin
Linagliptin/Metformin
Losartan/Hydrochlorothiazide
Lurasidone
Mavacamten
Memantine
Micafungin
Montelukast
Nebivolol
Olanzapine
Paliperidone
Perflutren
Pitavastatin
Pravastatin/Fenofibrate
Quetiapine
Rasagiline
Regadenoson
Resmetirom
Rivaroxaban
Rivastigmine
Rosa canina
Rosuvastatin
Rosuvastatin/Ezetimibe
Sacubitril
Safinamide mesylate
Selenium (75Se) Tauroselcholic Acid
Sitagliptin
Sitagliptin/Metformin
Sodium Iodide (123I)
Sugammadex
Sumatriptan
Technetium (99mTc) Nanocolloid
Teriflunomide
Tetrofosmin
Thiamine/Pyridoxine/Cyanocobalamin
Ticagrelor
Topiramate
Valsartan
Valsartan/Hydrochlorothiazide
Venlafaxine
Vinorelbine
Vortioxetine

PRESCRIPTION REQUIREMENT +

OTC (over-the-counter)
Rx (prescription required)

MARKETING AUTHORISATION HOLDER +

Blue Earth Diagnostics
GE Healthcare A.S.
Krka d.d.
Laboratoires Servier Industrie
Laboratoires SMB S.A.
Medi-Radiopharma (MRP)
Pharmazac S.A.
Provident Pharmaceuticals Ltd
Radiopharmacy Laboratorium KFT., Hungary
Synthaverse S.A.
TAD Pharma GmbH

Headquarters, Pharmaceutical Manufacturing Site & R&D Lab

1, A. Zaroliagki & 6, D. Lamprou Str.
GR-19001 Keratea
Greece
Center: +30 210 3418889-97
e-mail: pharmazac@pharmazac.com

Radiopharmaceutical Manufacturing Site

Lamia Industrial Zone, 3 & 3A Str.
OT 4B, GR-35100 Lamia
Greece
Center: +30 210 3418889-95

Report an Adverse Event / Pharmacovigilance

For any adverse event report
please contact Errietta Economou,
Head of Vigilance
Mobile: +30 6946463306 (24/7)
e-mail: eeconomou@vigi-care.eu

Corporate Statements and Publications

Media Material
Corporate Presentation
CMO/CDMO Services

Web Design & Development by Generation Y

0

$0.00

No translations available for this page

✕

Σύνδεση

Όνομα χρήστη ή email *

Συνθηματικό *

Να με θυμάσαι

Χάσατε το συνθηματικό πρόσβασής σας;

Learn More

DPP‑4 inhibitor

THERAPEUTIC AREA -

PHARMACOLOGICAL CLASS +

BUSINESS UNIT +

ACTIVE SUBSTANCE +

PRESCRIPTION REQUIREMENT +

MARKETING AUTHORISATION HOLDER +

Linagliptin

Meliglix®